Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Seaport Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Seaport Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Seaport Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Seaport Therapeutics, Inc.Listing unverified | Buy | $19.8M | conv 48 | SEC | |
Seaport Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Metsera, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Metsera, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Neumora Therapeutics, Inc.Listing on record | Buy | $5M | conv 50ClusterFirst in 12mo | SEC | |
Prime Medicine, Inc.Listing on record | Buy | $20M | conv 64ClusterUnusual size | SEC | |
Neumora Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Neumora Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Neumora Therapeutics, Inc.Listing on record | Buy | $347.2K | conv 42Cluster | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $255.1K | conv 50ClusterFirst in 12mo | SEC | |
Neumora Therapeutics, Inc.Listing on record | Buy | $497.6K | conv 43Cluster | SEC |